• +41 91 682 20 40
  • info@elixi-int.com
  • Reserved Area
    • Login
    • Register
    • Request Document
    • Send Document
logo
  • Home
  • About Us
  • Services
  • Quality
  • News
  • Case Studies
  • Contact

Let's talk

info@yourwebsite.com
+1 (555) 123-4567

  • Search

Elixi

26 January 2021

RINVOQ™ (Upadacitinib), approved for the Treatment of Psoriatic Arthritis and Ankylosing Spondylitis


0 Comments3 Minutes

19 January 2021

XALKORI (CRIZOTINIB) approved for ALK-POSITIVE anaplastic large cell LYMPHOMA in children and young adults


0 Comments2 Minutes

18 January 2021

Enhertu (trastuzumab deruxtecan) first HER2-directed medicine approved in a decade for patients with HER2-positive metastatic gastric cancer


0 Comments3 Minutes

12 January 2021

Xofluza® (baloxavir marboxil), a first-in-class, single-dose oral medicine, for the treatment of influenza,


0 Comments3 Minutes

8 January 2021

Glucagon for injection USP, First Generic of Drug Used to Treat Severe Hypoglycemia


0 Comments4 Minutes

5 January 2021

Ibrance, Palbociclib, is the #1 prescribed, FDA-approved oral combination treatment for HR+, HER2- mBC.


0 Comments2 Minutes

22 December 2020

Libmeldy, world’s first lentiviral vector-based gene therapy for the treatment of metachromatic leukodystrophy (MLD)


0 Comments5 Minutes

21 December 2020

PALFORZIA® [defatted powder of Arachis hypogaea L., semen (peanuts)]approved in the EU for the treatment of peanut allergy


0 Comments1 Minutes

19 December 2020

Tagrisso (osimertinib) , First Adjuvant Therapy for Most Common Type of Lung Cancer


0 Comments2 Minutes

3 December 2020

Gallium 68 PSMA-11 (Ga 68 PSMA-11)is the First PSMA-Targeted PET Imaging Drug for Men with Prostate Cancer


0 Comments3 Minutes

  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 13